BIOTEC researcher Dr. Sebastian Salentin receives Commerzbank dissertation prize

This year again, the dissertation prizes of Commerzbank and the Dr. Walter Seipp Prize will be awarded for outstanding dissertations by young scientists of the TU Dresden. Among the prize winners is Dr. Sebastian Salentin from the Biotechnology Center of the TU Dresden (BIOTEC). He receives one of Commerzbank's 2017 dissertation prizes and 1,000 euros in prize money.

Dr. Sebastian Salentin holds a PhD at BIOTEC on "In Silico Identification of Novel Cancer Drugs with 3D Interaction Profiling". He used computer-aided methods to discover new applications for known active ingredients. For example, he has shown that an antimalarial drug in cancer cells can improve chemotherapy by preventing cancer cells from developing resistance. "This award confirms me and motivates me to continue my scientific work. I am now working with other members of the research group of Prof. Michael Schroeder, my supervisor, on a spin-off. We want to show that our methods can be widely applied and can thus improve drug research," said Sebastian Salentin.

The prizes donated by Commerzbank AG will be awarded for the 22nd time this year, and the Dr. Walter Seipp Prize from the Commerzbank Foundation fund of the same name has been in existence for 21 years. Dr. Walter Seipp was Chairman of the Board of Managing Directors and the Supervisory Board of Commerzbank for many years.

Further information on the award ceremony